News Quantified

APTO – aptose biosciences, inc. - common shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Aptose Biosciences Inc. (NASDAQ: APTO) had its price target lowered by analysts at HC Wainwright from $7.00 to $2.00. They now have a "buy" rating on the stock.

Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy [Yahoo! Finance]

Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy

Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

-5.0%

BEAT

-4.1%

BEAT

Form 8-K Aptose Biosciences Inc. For: Nov 20

Form SC 13G Aptose Biosciences Inc. Filed by: ARMISTICE CAPITAL, LLC

Form 10-Q Aptose Biosciences Inc. For: Sep 30

Form 8-K Aptose Biosciences Inc. For: Nov 08

Form S-1/A Aptose Biosciences Inc.

Top News Gainers

12/7 Aptose Presents Highlights From Corporate Event At ASH 35.1%

3/12 Form 4 Aptose Biosciences Inc. For: Mar 10 Filed by: Chow Gregory K. 20.7%

1/9 Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $10.00 price target on the stock. 10.0%

5/30 Aptose Announces Pricing of Public Offering of Common Shares 9.9%

12/18 Form 424B5 Aptose Biosciences Inc. 9.3%

5/29 Aptose Biosciences Inc. (NASDAQ: APTO) had its "buy" rating re-affirmed by analysts at Roth Capital. 8.7%

10/22 Aptose To Release Third Quarter Ended September 30, 2019 Financial Results and Hold Conference Call on November 5, 2019 8.5%

4/14 Aptose Biosciences Inc. (NASDAQ: APTO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $7.50 price target on the stock. 8.0%

3/16 Aptose Biosciences Inc. (NASDAQ: APTO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $6.00 price target on the stock. 7.6%

1/29 Aptose Biosciences to Host Key Opinion Leader Event Present at BIO CEO & Investor Conference 7.2%

Top News Decliners

3/10 Form 10-K Aptose Biosciences Inc. For: Dec 31 -21.6%

3/12 Aptose Biosciences Inc. (NASDAQ: APTO) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -18.3%

4/27 Aptose Presents Preliminary Clinical Data on CG-806 at AACR Virtual Annual Meeting 2020 -12.6%

12/17 Aptose up 3% after pricing stock offering [Seeking Alpha] -11.7%

8/6 Form 8-K Aptose Biosciences Inc. For: Aug 06 -9.7%

4/29 Aptose Biosciences Inc. (NASDAQ: APTO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -9.3%

3/13 Form 4 Aptose Biosciences Inc. For: Mar 11 Filed by: PLATZER ERICH -8.8%

5/29 Aptose Announces Proposed Public Offering of Common Shares -7.4%

12/24 Aptose Biosciences Inc. (NASDAQ: APTO) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -7.3%

9/16 Aptose to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Companies -7.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day